NASH Emerging Therapies: Transforming the Nonalcoholic Steatohepatitis Landscape Nonalcoholic steatohepatitis (NASH) is an increasingly prevalent liver disease characterized by inflammation and fibrosis due to fat accumulation in the liver, not related to alcohol consumption. With the growing incidence of obesity and type 2 diabetes, NASH has become a significant public health concern,...